Latest Breaking News On - Academic external affairs - Page 3 : comparemela.com

The Oxford-Harrington Rare Disease Centre Launches Pioneering Therapeutics Accelerator to Advance Innovative Treatments for Rare Diseases

The Therapeutics Accelerator (the Accelerator ) will identify, fund and advance innovative projects from academic partners in the U.K. and U.S. with the goal.

United statesUnited kingdomEd busseyRonaldg harringtonDavid cameronJonathan stamlerJohn bellMatthew woodCliffa megerianDanieli simonGeorg hollOxford harrington rare disease centre therapeutics acceleratorFounder of harrington discovery instituteOxford science enterprisesOxford harrington rare disease centre advisory boardOxford university medical sciences division

Oxford-Harrington Launches Therapeutics Accelerator for Rare Diseases

Oxford-Harrington Launches Therapeutics Accelerator for Rare Diseases
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomEd busseyMatthew woodGeorg hollCliffa megerianRonaldg harringtonJohn bellJonathan stamlerDavid cameronDanieli simonHead of department paediatricsFounder of harrington discovery instituteUniversity hospitals in clevelandHarrington discovery instituteUniversity hospitals

New Study Confirms HeartFlow FFRCT Leads to Improved Patient Outcomes

University Hospitals Harrington Heart & Vascular Institute first to adopt technology in U.S.

United statesNoord hollandMehdi shishehborHiram bezerraCampbell rogersJames hambrickUh harrington heart vascular instituteAcademic external affairsNational health service englandHeartflow incUniversity hospitals uh harrington heart vascular instituteUh harrington heart vascular institute daniel simonHealth care leadership at university hospitalsEuropean society of cardiology congressUniversity hospitalsHarrington heart

Researchers validate first-ever AI biomarker for ADT benefit in prostate cancer

Data from a new study published in NEJM Evidence shows promise for personalized use of short-term ADT in men with predominantly intermediate-risk prostate cancer.

Case western reserve universityUnited statesLee seidmanDaniel sprattTheodoros teknosDanielle ellisVincentk smithGary schwartzDanieli simonCancer centerDepartment of radiation oncologyCase comprehensive cancer centerUniversity hospitals uh seidman cancer centerAcademic external affairsUniversity hospitalsCase comprehensive center

Study validates first-ever predictive AI biomarker of androgen deprivation therapy benefit in prostate cancer

Study validates first-ever predictive AI biomarker of androgen deprivation therapy benefit in prostate cancer
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United statesCase western reserve universityVincentk smithLee seidmanTheodoros teknosGary schwartzDaniel sprattDanieli simonDaniele sprattDepartment of radiation oncologyCancer centerUniversity hospitalsCase comprehensive centerUh seidman cancer centerUniversity hospitals uh seidman cancer centerCase comprehensive cancer center